CrisprBits, a biotech start-up specializing in CRISPR gene-editing technology, is excited to announce a strategic collaboration with Molbio Diagnostics, a pioneer in point of care diagnostic solutions. The intent of this collaboration is to revolutionize point of care diagnostics by the introduction of CRISPR in
Partnership will expand use of next-generation sequencing (NGS) to help diagnose patients quickly and more accurately Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing
